Xiaoying Zhao

623 total citations
35 papers, 501 citations indexed

About

Xiaoying Zhao is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaoying Zhao has authored 35 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Xiaoying Zhao's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Xiaoying Zhao is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Xiaoying Zhao collaborates with scholars based in China, United States and Croatia. Xiaoying Zhao's co-authors include Yun Liang, Lei Zhu, Rongzhen Xu, Xiaohua Xu, Lei Zhang, Xuyan Yang, Haiyan Wang, Weiqin Wang, Xiaoyong Lu and Jin Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xiaoying Zhao

32 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoying Zhao China 13 245 108 89 86 70 35 501
Junichi Hisatake Japan 11 424 1.7× 86 0.8× 76 0.9× 119 1.4× 149 2.1× 21 784
Li Cao China 12 258 1.1× 91 0.8× 55 0.6× 48 0.6× 167 2.4× 27 539
Kang Zheng China 12 204 0.8× 27 0.3× 60 0.7× 58 0.7× 44 0.6× 18 480
Jyoti Kureel India 13 440 1.8× 58 0.5× 16 0.2× 79 0.9× 182 2.6× 19 583
Wenjuan Yu China 15 295 1.2× 27 0.3× 257 2.9× 107 1.2× 42 0.6× 87 618
Szu-Yu Kuo Taiwan 10 228 0.9× 57 0.5× 28 0.3× 54 0.6× 46 0.7× 15 497
Robert C. Bertheau United States 9 275 1.1× 20 0.2× 39 0.4× 85 1.0× 24 0.3× 18 512
Yuzhou Pang China 12 148 0.6× 33 0.3× 40 0.4× 50 0.6× 64 0.9× 24 411
Yoshimi Kakiuchi Japan 13 183 0.7× 208 1.9× 19 0.2× 86 1.0× 62 0.9× 23 630
Jianlin Huang China 14 202 0.8× 19 0.2× 52 0.6× 39 0.5× 59 0.8× 35 481

Countries citing papers authored by Xiaoying Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Zhao more than expected).

Fields of papers citing papers by Xiaoying Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Zhao. The network helps show where Xiaoying Zhao may publish in the future.

Co-authorship network of co-authors of Xiaoying Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Zhao. A scholar is included among the top collaborators of Xiaoying Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Zhao. Xiaoying Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Sheng, Xiaoying Zhao, Juan Zhou, & Mingjuan Sun. (2025). Apatinib monotherapy for pretreated advanced squamous cell carcinoma of the penis: A phase II trial.. Journal of Clinical Oncology. 43(5_suppl). 8–8.
2.
Peng, Liang, Xingyu Li, Yixin Chen, et al.. (2025). Automated cardiac magnetic resonance interpretation derived from prompted large language models. Cardiovascular Diagnosis and Therapy. 15(4). 726–737.
3.
Zhang, Wenjing, et al.. (2023). Clinical evaluation of a new COVID-19 antigen rapid test kit for detection of SARS-CoV-2. Diagnostic Microbiology and Infectious Disease. 108(2). 116136–116136. 2 indexed citations
4.
5.
Zhang, Rui, et al.. (2022). The Relationship of Hyperferritinemia to Metabolism and Chronic Complications in Type 2 Diabetes. SHILAP Revista de lepidopterología. 4 indexed citations
6.
Gong, Rui, et al.. (2022). Coronavirus Disease 2019 (COVID-19) vaccines and menstrual cycle length. 4(1). 5–5. 1 indexed citations
7.
Yu, Teng, et al.. (2019). Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study. International Journal of Laboratory Hematology. 41(3). 380–386. 1 indexed citations
8.
Zhao, Xiaoying, et al.. (2018). Secondary mixed phenotype acute leukemia following chemotherapy for diffuse large B-cell lymphoma: a case report and review of the literature.. PubMed. 11(6). 3104–3110. 1 indexed citations
9.
10.
Lü, Ying, Fenglin Li, Qitian Mu, et al.. (2015). [The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients].. PubMed. 36(5). 372–7. 3 indexed citations
11.
Yuan, Xianggui, et al.. (2012). Oestrogen‐deficiency inducing haematopoiesis dysfunction via reduction in haematopoietic stem cells and haematopoietic growth factors in rats. International Journal of Experimental Pathology. 93(3). 179–187. 15 indexed citations
12.
Xu, Xiaohua, Yichao Gan, Ting Chen, et al.. (2012). Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. Journal of Zhejiang University SCIENCE B. 13(11). 867–874. 18 indexed citations
13.
Zhu, Lei, et al.. (2009). Ovariectomy‐associated changes in bone mineral density and bone marrow haematopoiesis in rats. International Journal of Experimental Pathology. 90(5). 512–519. 78 indexed citations
14.
15.
Liang, Yun, et al.. (2009). The Antiproliferation Effect of Berbamine on K562 Resistant Cells by Inhibiting NF‐κB Pathway. The Anatomical Record. 292(7). 945–950. 20 indexed citations
16.
Liang, Yun, et al.. (2009). Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacologica Sinica. 30(4). 451–457. 43 indexed citations
17.
Wang, Weiqin, Xiaoying Zhao, Haiyan Wang, & Yun Liang. (2008). Increased fatty acid synthase as a potential therapeutic target in multiple myeloma. Journal of Zhejiang University SCIENCE B. 9(6). 441–447. 37 indexed citations
18.
Wu, Xianguo, et al.. (2007). Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study. Journal of Zhejiang University SCIENCE B. 8(8). 570–574. 4 indexed citations
19.
Yang, Xuyan, Jin Lin, Xiaoyong Lu, & Xiaoying Zhao. (2007). Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus. Clinical Rheumatology. 27(3). 353–357. 32 indexed citations
20.
Xu, Rongzhen, Qinghua Dong, Xiaoying Zhao, et al.. (2005). Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leukemia Research. 30(1). 17–23. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Hisatake Breakdown of academic impact, for papers by Li Cao Breakdown of academic impact, for papers by Kang Zheng Breakdown of academic impact, for papers by Jyoti Kureel Breakdown of academic impact, for papers by Wenjuan Yu Breakdown of academic impact, for papers by Szu-Yu Kuo Breakdown of academic impact, for papers by Robert C. Bertheau Breakdown of academic impact, for papers by Yuzhou Pang Breakdown of academic impact, for papers by Yoshimi Kakiuchi Breakdown of academic impact, for papers by Jianlin Huang
Rankless by CCL
2026